ACT DMD Update with PTC (February 2014) On February 5, 2014, Dr. Robert Spiegel, Chief Medical Officer at PTC Therapeutics, presented an update about PTC’s Phase 3 study of ataluren, now known as the Ataluren Confirmatory Trial in DMD (ACT DMD). Research & Clinical Trial Webinars,Webinars 11 years ago You may also like 45:44 Family Friday: End of the School Year & Looking Ahead 5 years ago Family Friday,Webinars 48:02 Family Friday: Sibling Relationships 5 years ago Family Friday,Webinars 1:02:19 Making the Most of Your Telehealth Appointments (May 6, 2020) 5 years ago Care Webinars,COVID-19 Webinars,Webinars 47:30 Family Friday: Managing Learning Challenges at Home 5 years ago Family Friday,Webinars 1:00:26 Access to Approved Therapies and Home Care (April 29, 2020) 5 years ago Care Webinars,COVID-19 Webinars,Webinars 54:06 Italfarmaco Provides Givinostat Update (April 22, 2020) 5 years ago Research & Clinical Trial Webinars,Webinars 34:10 Family Friday: Healthy & Fun Cooking at Home 5 years ago Family Friday,Webinars 42:59 Family Friday: COVID-19, Social Distancing, & Quarantine – Coping with Stress and Anxiety 5 years ago Family Friday,Webinars «1…1011121314…25»Page 12 of 25
by: Parent Project Muscular Dystrophy
